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Abstract
Background: Ménière’s disease (MD) is a common inner ear disorder which is characterized by recurrent attacks of vertigo, 
fluctuating sensorineural hearing loss (SNHL), tinnitus, and a sense of fullness in the affected ear. MD is a complex disorder; 
although six genes have been linked to familial autosomal dominant form of the disease, in many cases, the exact genetic etiology 
remains elusive.
Methods: To elucidate the genetic causes of MD in an Iranian family, we performed exome sequencing on all members of the 
family: consanguineous parents and four children (two affected and two unaffected). Variant filtering was completed using a 
customized workflow keeping variants based on segregation with MD in autosomal recessive (AR) inheritance pattern, minor 
allele frequency (MAF), and in-silico prediction of pathogenicity.
Results: Analysis revealed that in this family, 970 variants co-segregated with MD in AR pattern, out of which eight variants (one 
intergenic, four intronic, and three exonic) were extremely rare. The exonic variants included a synonymous substitution in USP3 
gene, an in-frame deletion in ZBED2 gene, and a rare, highly conserved deleterious missense alteration in LSAMP gene. 
Conclusion: The phenotype observed in the proband described here, i.e. vertigo, poor sense of smell, tinnitus, and borderline 
hearing ability, may originate from aberrant changes in the cerebellum and limbic system due to a deleterious mutation in the 
LSAMP gene; hence, LSAMP mutation is a possible candidate for the etiology of MD in this family.
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Diseases which display phenotypic heterogeneity, 
pleiotropy and incomplete penetrance, often arise from 
a complex combination of etiological factors, including 
genetic and environmental components. As such, these 
diseases are often hard to characterize and consequently, 
it is difficult to elucidate the genetics and pathophysiology 
underlying the disease, as is the case with Ménière’s 
disease (MD [MIM 156000]). MD is a complex disease 
which displays considerable clinical heterogeneity. The 
broad clinical spectrum of symptoms includes episodes 
of spontaneous vertigo lasting from 20 minutes to several 
hours1,2 becoming less frequent but more severe over 
time.3 Sensorineural hearing loss (SNHL) typically begins 
at low frequencies and fluctuates, ultimately resulting in 
progressive moderate to severe hearing loss.1,3-5 Alongside 
vertigo and SNHL, patients often experience aural fullness 
and tinnitus, an imaginary but debilitating sensation of 
ringing, buzzing, or hissing. MD symptoms mainly affect 
one ear (unilateral MD); however, bilateral MD has also 
been reported.1,5,6 Broadly, MD falls into two clinical 
categories: definite and probable, with probable being less 
phenotypically severe.7 MD usually begins to manifest 
in the third to the seventh decades of life with a small 
female predominance, and only a few rare cases have been 
identified in younger people.2,7,8
The prevalence of MD is estimated to be roughly 0.5–
1/1000 individuals.1,6,7,9,10 Among these, approximately 
10% are familial MD (FMD),4 in which at least one 
other relative (first- or second-degree) fulfills all of the 
criteria for definite or probable MD.3,4,11 While FMD and 
sporadic MD exhibit the same phenotypes, there is often 
greater severity and earlier onset in FMD.3,4,8,12 FMD has 
been described in families originating from the UK, Brazil, 
Sweden, Finland, Germany, and Spain.3,4,6,10-13 Outside the 
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many populations.2,12 It is considered to be a multifactorial 
disorder and the clinical heterogeneity observed among 
patients points to the suggested etiological diversity 
including environmental and genetic factors, dysfunction 
of the immune system, and viral infections.4,9 The fact 
that approximately one-third of MD patients have family 
members with MD-like symptoms, and different MD 
incidences in different populations lend credence to the 
role of genetics in the development of MD.11
MD can be inherited in autosomal dominant (AD), 
and rarely in mitochondrial or recessive patterns.3,4,6,12,13 
Mutations in DTNA, FAM136A, COCH, DPT, 
SEMA3D, and PRKCB genes have been described in 
ADFMD2,14–16; however, no gene has been identified for 
recessive inheritance. Here, we describe a consanguineous 
Iranian family with autosomal recessive (AR) FMD. After 
detailed genetic analysis, we conclude that a mutation of 
the gene encoding the limbic system associated membrane 
protein (LSAMP) plays a role in ARFMD.
Materials and Methods
An Iranian Lur family (L-8600471) with apparent ARFMD 
was selected for this study. Clinical examination, including 
brain MRI, was performed. Pure tone audiometry was 
carried out to determine air conduction thresholds at 0.25, 
0.5, 1, 2, 3, 4 and 8 kHz. After obtaining informed consent, 
whole blood samples were collected from all members of 
the core family including both individuals affected with 
ARFMD, unaffected siblings and both parents. DNA was 
extracted using the conventional salting out method.17 
All procedures were approved by the human research 
institutional review boards at the University of Social 
Welfare and Rehabilitation Sciences and Iran University 
of Medical Sciences, Tehran, Iran.
Targeted genomic enrichment (TGE) was performed 
using either the Agilent SureSelect Human All Exon 
kit (v.5) or the Agilent SureSelect XT Human All Exon 
kit (v.6) (Agilent Technologies, Inc., Santa Clara, CA, 
USA). Captured genomic libraries underwent subsequent 
massively parallel sequencing (MPS) using the Illumina 
HiSeq2000 or the Illumina NextSeq 500 platform 
(Illumina Inc., San Diego, CA, USA). After sequencing, 
raw reads were aligned to the hg19 build of the human 
reference genome using Burrows-Wheeler Aligner (BWA), 
MEM algorithm.18 Data processing and variant discovery 
(SNPs and Indels) were performed according to the 
best practices workflow of the Genome Analysis Toolkit 
(GATK).19,20 Variants were listed in a gVCF file per sample 
which were then merged together. Variant annotation 
was performed using ANNOVAR software.21 Annotated 
variants underwent filtering and prioritization based on 
the AR mode of inheritance. Those variants were kept 
for which both parents were heterozygous, both healthy 
siblings were wild type homozygous or heterozygous, and 
both affected siblings were mutated homozygous. Variants 
were further prioritized considering their frequencies in 
the 1000 Genome project, ExAC, ESP6500, genomAD, 
exomAD, and Iranome databases (http://iranome.
com/).22–24 The prioritizing cut-off started at minor allele 
frequency (MAF)<0.05 and then narrowed down to 0.01, 
0.001, and finally 0.0001.
Results
Family L-8600471 originates from western Iran and is of 
Lur ethnicity with consanguineous parents (Figure 1a). 
Brain MRI was normal in proband IV:3. Audiological 
examination revealed borderline hearing in both ears of 
proband IV:3 (Figure 1b). She complained of vertigo, a 
sense of vomiting, tinnitus, hearing impairment, and poor 
sense of smell, with onset around 30 years of age. After 
clinical examination, she was diagnosed with definite MD. 
The same phenotypes, apart from a poor sense of smell, 
were reported in the proband’s sister (IV:4) with onset at 
45 years of age; she also had a history of depression.
After applying variant filtering, as described in methods, 
970 variants remained that were inherited in an AR 
pattern. Then, the variants were prioritized in terms of 
MAF based on publicly available databases of the 1000 
Genome project, ESP6500, ExAC, gnomAD genome, 
and gnomAD exome (<5%, <1%, <0.1%, and <0.01%), 
Figure 1. (a) Pedigree of family L-8600471. (b) Audiogram of proband IV:3 
(I-16800).
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resulting in 72, 46, 20, and 14 variants, respectively. 
Further investigation in 800 Iranian individuals (Iranome 
database) removed four variants with MAF >0.01%. The 
remaining variants were rechecked for quality with the 
Integrative Genomics Viewer (IGV) and two variants did 
not have sufficiently high quality. Out of the remaining 
eight variants, three were exonic, four intronic and one 
intergenic (Table 1). The three exonic variants included 
a synonymous variant in USP3 [MIM:604728] gene, 
a 3-bp variant in ZBED2 [MIM:615246] gene that was 
predicted to be a polymorphism, and a highly conserved 
and predicted deleterious missense variant in LSAMP 
[MIM:603241] gene (Table 2).
Discussion
MD is a complex disorder. It displays great inter- and 
intra-familial phenotypic heterogeneity and the exact 
pathomechanisms and genetic etiology underlying these 
phenotypes remain, for the most part, elusive. In this 
study, we utilized the power of exome sequencing on a 
Table 1. Variants Identified in the Affected Individuals in Family L-8600471
Gene Variant Type
OR5H2;OR5K4 Chr3:98030901A>C Intergenic
ZBED2 Chr3:111313042TCA>- Exonic (in frame deletion)




USP3 Chr15:63848878A>C Exonic (synonymous)
BAGE Chr21:11088848A>T Intronic

























Grantham Matrix score 56
consanguineous Iranian family with apparent ARFMD to 
implicate the LSAMP gene in the pathobiology of MD.
For decades, families from consanguineous regions 
have been used to investigate the molecular genetics 
of diseases.25-27 To this list of diseases, we add MD. 
We have identified a nonsynonymous variant 
(chr3:115561402T>C; c.673A>G; p.K225E) in the 
gene encoding the limbic system associated membrane 
protein (LSAMP) (Figure 2). Affected individuals were 
homozygous, and unaffected siblings and parents were 
heterozygous for this mutation (Figure 3). The p.K225E 
variant occurs in the highly conserved lysine 225 residue 
(Figure 4). The change from positively charged lysine to 
the negatively charged glutamic acid is predicted to be 
deleterious (Table 2) and most likely has a negative impact 
on local protein folding. It is predicted that this variant 
perturbs wild-type function either by disrupting a site for 
protein interactions or by altering folding.
LSAMP is a neuronal surface adhesion glycoprotein 
in cortical and subcortical regions of the limbic system. 
It takes part in neurite outgrowth, development of 
neuronal connection patterns and synaptic plasticity 
with an essential role in regulating the formation of 
septohippocampal, intrahippocampal, and thalamic 
connections.28-31 LSAMP is expressed in the hippocampus, 
cerebellum, eye, urogenital system, liver, heart, skeletal 
muscle, and small intestine.31–33 LSAMP is a candidate in 
the susceptibility to familial clustering of schizophrenia, 
bipolar disorder, and major depressive disorder.34 SNPs 
in LSAMP have been reported to have an association 
of genome-wide significance with ulcerative colitis in 
African Americans.33 LSAMP is also suggested to be a 
tumor suppressor and its genomic deletion is reported 
in aggressive prostate cancer, osteosarcoma, clear cell 
renal cell carcinoma, epithelial ovarian cancer, and acute 
myeloid leukemia.33,35,36 LSAMP downregulation has been 
shown to be associated with coronary artery disease.37 
Animal studies have shown alteration in the regulation of 
emotional and social behavior in a changing environment 
in LSAMP-deficient mice.32,36,38
Cerebellum involvement has been established in 
cognitive and sensory motor processes such as maintaining 
balance, olfactory and auditory activities.39-42 It has been 
shown that PFL and vermis regions in the cerebellum 
are connected to auditory centers, response to sound and 
involvement in tinnitus perception.42,43 The potential role 
of structures in the limbic system in auditory processing 
and tinnitus has been suggested in various studies.44-48 
The hippocampus, one of the structures in the limbic 
system, has a bilateral connection with auditory cortices 
to provide and receive inputs.46 Chan et al showed that 
the hippocampus coordinates brain-wide neural activities 
including auditory activity at slow oscillation.44 Uchida 
et al suggested an association between hearing loss and 
hippocampal atrophy.49 Seo et al reported a significant 
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reduction in hippocampus volume in MD patients.50
Tinnitus is a network problem that involves the auditory 
and limbic regions of the brain including the amygdala, 
hippocampus, and parahippocampus.45-47,51,52 Chen et al 
showed that pharmacologically induced tinnitus implies 
increased connections between the auditory cortex, the 
cerebellum and the hippocampal gyrus.43 Zhang et al 
suggested that cholinergic signaling in the hippocampus, 
which modifies its synaptic plasticity or excitability, may 
be involved in the pathophysiology of tinnitus.46 Crippa 
et al observed different strengths of connections between 
the auditory cortex and limbic structures in patients 
with tinnitus.48 It has been shown that methylamine 
intoxication or bilateral resection of the hippocampus 
Figure 2. (a) Two LSAMP transcripts adopted from UCSC genome browser. In each transcript, the location of the variant is shown by an arrow. (b) PSIPRED 
prediction for secondary structure of LSAMP protein. The lysine 225 residue is shown by a red rectangle. (c) SMART (a Simple Modular Architecture Research 
Tool) prediction for LSAMP domains. The arrow shows the location of the variant. Vertical lines show the location of introns.
Figure 3. Integrative Genomics Viewer (IGV) image for the Chr3:115561402T>C variant in LSAMP gene in family L-8600471. From top to bottom, sequence 
results for two parents, two affected siblings and two healthy siblings are illustrated.
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result in tinnitus development.53,54
In summary, we have identified a promising candidate 
gene (LSAMP) for ARFMD segregating in an Iranian family. 
The phenotype observed in the proband described here, 
i.e. vertigo, poor sense of smell, tinnitus, and borderline 
hearing ability, may originate from aberrant changes in 
the cerebellum and limbic system due to a deleterious 
mutation in the LSAMP gene. Further studies, including 
screening of MD patients for variants in the LSAMP gene 
and functional studies of the pathomechanism driving the 
disease, are needed to fully clarify the role of LSAMP in 
MD.
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